Washington: Researchers at the Columbia University Medical Center (CUMC) including Indian origin scientists have developed the first true mouse model of typhoid infection. The development promises to advance the study of typhoid and the creation of new vaccines against the infection, which remains a major health threat in developing countries. “Vaccines are the most practical solution for preventing typhoid in the Third World. Unfortunately, existing typhoid vaccines are only modestly effective, leaving millions of people vulnerable to infection. With our new mouse model, the first of its kind, we have a powerful tool for investigating the disease and devising better vaccine strategies,” said study co-leader Sankar Ghosh, PhD, the Silverstein and Hutt Family Professor and chair of microbiology and immunology at CUMC.Typhoid is caused by the bacterium Salmonella typhi, which is spread through contaminated drinking water or food. It is a common health problem in the developing world, affecting more than 2 million people each year and leading to 200,000 deaths.Symptoms of typhoid infection include high fever, fatigue, stomach pains, headache, and loss of appetite. Typhoid can be treated with antibiotics. Without therapy, the illness may last up to a month, with a fatality rate between 12 and 30 percent. There are two typhoid vaccines, with efficacy rates ranging from 50 to 80 percent.Since mice and other laboratory animals are resistant to S. typhi, it has been difficult to develop and test new vaccination approaches. In the current experiment, Dr. Ghosh and his colleagues sought to determine why mice couldn’t be infected with S. typhi, with the ultimate goal of creating an animal model for studying the disease.Evidence suggested that toll-like receptors (TLRs), which are expressed on the surface of key immune cells such as macrophages and dendritic cells, might be involved. Such cells are part of the innate immune response, the body’s first-line defense against infectious microbes. For various reasons, the researchers zeroed in on a particular TLR: TLR11. One, this receptor is expressed all over the gastrointestinal lining, or epithelium, where S. typhi infection begins, and two, the receptor is found in mice, but not in humans. Also, in an earlier study, the CUMC team found that TLR11 protects mice infected with the Toxoplasma gondii, the parasite that causes toxoplasmosis in humans.
Voting underway in Bihar bypolls
Heavy rains cripple Mumbai, again!
Students develop charger that charges as you walk!
Maharashtra CM Prithviraj Chavan not to share dais with Narendra Modi